Perceptive and Kayentis Forge Alliance to Unify Trial Systems

By Pamela Cox

NOTTINGHAM, England & MEYLAN, France – March 24, 2026 – In a significant move to streamline global clinical trials, Interactive Response Technology (IRT) leader Perceptive eClinical and electronic Clinical Outcome Assessment (eCOA) specialist Kayentis have announced a strategic partnership. The collaboration will deliver a fully integrated eCOA–IRT solution, aiming to dismantle the digital silos that have long plagued clinical research operations and burdened site staff.

This alliance provides clinical trial sponsors and contract research organizations (CROs) with a powerful ‘best-of-breed’ alternative to monolithic, single-vendor systems. By combining two highly specialized platforms into a seamless, unified experience, the partnership directly confronts one of the industry's most persistent challenges: the operational drag caused by a fragmented and disconnected technology ecosystem.

The Burden of a Fragmented Digital Landscape

For years, the clinical research industry has grappled with the consequences of data fragmentation. As trials grow in complexity, study teams are often forced to navigate a patchwork of disparate digital tools for managing different aspects of a study, from patient randomization and drug supply (IRT) to patient-reported outcomes (eCOA) and data capture (EDC). This fragmentation is not just a technical issue; it is a significant barrier to efficiency, a drain on resources, and a risk to data integrity.

Industry data underscores the scale of the problem. A 2019 survey found that 100% of respondents felt information exchange in clinical trials needed improvement, with system integration cited as a top concern. More recently, a 2024 poll identified technology integration as a significant challenge for a substantial portion of industry professionals. This digital friction manifests daily at clinical sites, where staff are often required to log into multiple systems, perform redundant data entry, and conduct laborious manual reconciliation steps. The result is an increased administrative workload that diverts valuable time and attention away from patient care and critical research activities.

This environment of isolated systems can slow scientific progress and increase costs. When essential information is scattered across non-interoperable platforms, it can lead to duplicated, isolated, or even lost data, potentially compromising trial timelines and the quality of evidence generated. Each day a trial is delayed due to poor data access can represent hundreds of thousands of dollars in lost revenue potential, making the case for integrated solutions more urgent than ever.

A 'Best-of-Breed' Answer to a Complex Problem

The partnership between Perceptive eClinical and Kayentis represents a strategic counterpoint to the idea that a single, all-in-one platform is the only solution. Instead, they are championing a 'best-of-breed' model, which argues that combining top-tier, specialized systems can offer greater functionality and flexibility than a one-size-fits-all approach. Perceptive eClinical brings over 30 years of experience in IRT with its trusted ClinPhone Pro platform, while Kayentis is a recognized global expert in eCOA, known for its patient-centric technology and high client recommendation rates.

The move reflects a broader industry trend. Companies like Suvoda, IQVIA, and Signant Health have also been developing integrated platforms, recognizing the market's clear demand for unified workflows. The Perceptive-Kayentis alliance enters this competitive landscape by wedding two established, purpose-built platforms, promising deep, systematic integration rather than a simple surface-level connection.

“Our alliance with Kayentis reflects our shared ambition to build a more unified and intelligent clinical technology environment,” said Mario Papillon, CEO of Perceptive eClinical, in the original announcement. “By connecting two highly innovative, purpose-built platforms, we are delivering a coordinated solution that simplifies operations, reduces the burden on site teams and strengthens data quality for sponsors and CROs.”

This sentiment was echoed by Kayentis CEO Guillaume Juge, who framed the partnership as an extension of his company's mission. “This combined eCOA–IRT workflow offers clearer processes, fewer systems to manage and more reliable data for decision-making,” he stated.

Streamlining Operations from Setup to Closeout

The true test of any integration lies in its practical benefits. The joint Perceptive-Kayentis solution promises tangible improvements designed to accelerate daily operations and enhance data quality. Key functionalities include unified user access for a seamless experience across both platforms, eliminating the need for multiple logins and passwords.

Perhaps most importantly, the system automates the transfer of critical patient information, such as patient numbers and demographic data. This single stroke eliminates a major source of manual re-entry, which is not only time-consuming but also a significant source of human error. By some industry estimates, similar integrations have been shown to reduce sponsor and clinical team effort during study start-up by as much as 50%.

Furthermore, the integrated platform will feature automated workflow triggers based on shared data. For example, patient-reported outcomes entered into the eCOA system could automatically trigger a drug re-supply event in the IRT system or alert investigators to an adverse event. This real-time data exchange allows for faster, more confident decision-making throughout the trial lifecycle, from screening and randomization to dosing adjustments and final reporting. Beyond the technical features, the partnership also aims to simplify study governance by offering a single administrative contract, aligned project milestones, and coordinated delivery teams, reducing friction from study initiation through to database lock.

Empowering Sites and Navigating the Path Forward

Ultimately, the success of this partnership will be measured by its impact on the people at the heart of clinical research: the site staff and the patients. By reducing the technological burden, the integrated solution aims to free up clinical coordinators and investigators to focus on what they do best—providing patient care and ensuring the integrity of the research. A simplified, intuitive system can lead to a better experience for site teams, potentially improving staff retention and trial performance.

However, the path to widespread adoption is not without its challenges. The clinical trial industry is notoriously cautious, and overcoming inertia requires a clear demonstration of value. Sponsors and CROs often have long-term contracts with existing vendors, and the process of switching systems can be complex and costly. Effective change management, robust training protocols for site staff, and ensuring compatibility with other essential systems like Electronic Data Capture (EDC) will be critical for the partnership’s success.

Both Perceptive eClinical and Kayentis have acknowledged that this is just the beginning. Their announcement included a commitment to a “shared roadmap focused on deeper integration across the full clinical ecosystem.” This forward-looking statement suggests a long-term vision to expand interoperability, potentially connecting with other critical trial systems to create an even more cohesive and intelligent technology environment. This ambition aligns with the industry's ultimate goal: to run faster, more efficient, and more patient-centric trials.